BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 17, 2009
View Archived Issues
Ariad presents first interim analysis of phase III ridaforolimus trial in metastatic sarcoma
Read More
Protox Therapeutics presents 12-month phase II PRX-302 results
Read More
Mpex reports phase II results with Aeroquin, delivered by eFlow technology
Read More
Salix reports results for rifaximin in non-constipation irritable bowel syndrome
Read More
Vical's influenza vaccine demonstrates cross-reactivity against H1N1 strains
Read More
Aeolus initiates second AEOL-10150 study as a countermeasure to radiation
Read More
Cell Therapeutics submits Pediatric Investigation Plan to EMEA for pixantrone
Read More
Esperance commences clinical studies of EP-100 in cancer
Read More
Diabetes Research Centers collaborate on phase II Exsulin trial
Read More
Protalix BioTherapeutics completes pivotal phase III prGCD trial for Gaucher's disease
Read More
Combined tamibarotene and arsenic trioxide to be studied for acute promyelocytic leukemia
Read More
FDA approves four influenza A (H1N1) 2009 monovalent vaccines
Read More
PAR1 antagonists for the treatment of thrombosis disclosed by sanofi-aventis
Read More
Novel renin inhibitors in development at sanofi-aventis for the treatment of hypertension
Read More
Follicle-stimulating hormone receptor activators for female infertility disclosed by Organon
Read More
Noscira claims novel beta-secretase 1 and GSK-3beta inhibitors for AD
Read More
Boehringer Ingelheim discloses EGFR inhibitors for the treatment of cancer
Read More
Duloxetine produces sustained pain reduction in patients with chronic low back pain
Read More
Population PK/PD modeling predicts optimal dosing regimen of TV-1102
Read More
Integrin receptor antagonist GLPG-0187 inhibits metastatic tumor growth and bone tumor burden
Read More
In vivo anti-ulcerative activity exhibited by chitosan
Read More
BL-1020 meets primary and secondary endpoints in phase IIb EAGLE trial
Read More
Panobacumab safe in patients with hospital-acquired pneumonia
Read More
Phase I data show MGCD-290 to be well tolerated, with favorable pharmacokinetics
Read More
Ascenta Therapeutics obtains clearance by the FDA for its IND application for AT-406
Read More
Biotie Therapies commences clinical study with phosphodiesterase 4 inhibitor ELB-353
Read More